.Pharmacolibrary.Drugs.ATC.R.R03BA02_1 .Pharmacolibrary.Drugs.ATC.R.R03BA02_1| name: | Budesonide_1 |
| ATC code: | R03BA02_1 | route: | inhalation |
| n-compartments | 2 |
Budesonide is a synthetic corticosteroid with potent glucocorticoid activity. It is commonly used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and inflammatory bowel disease (such as Crohn's disease and ulcerative colitis). It is approved and widely used in inhaled, oral, and rectal formulations due to its high first-pass metabolism, which minimizes systemic side effects.
Pharmacokinetic parameters for healthy adults after inhaled administration (metered-dose inhaler).
Donnelly, R, & Seale, JP (2001). Clinical pharmacokinetics of inhaled budesonide. Clinical pharmacokinetics 40(6) 427–440. DOI:10.2165/00003088-200140060-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11475468
Roberts, JK, et al., & Ward, RM (2016). Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials. Current clinical pharmacology 11(1) 53–61. DOI:10.2174/1574884710666150929100210 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26416605
Simeoli, R, et al., & Goffredo, BM (2024). Pharmacokinetic Evaluation of Oral Viscous Budesonide in Paediatric Patients with Eosinophilic Oesophagitis in Repaired Oesophageal Atresia. Pharmaceutics 16(7) –. DOI:10.3390/pharmaceutics16070872 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39065569